0
0.5
1
1.5
2+
Ventilation, 24mg
67%
Improvement
Relative Risk
Ventilation, 12mg
33%
Hospitalization, 24mg
46%
primary
Hospitalization, 12mg
27%
primary
Recovery, 24mg
39%
Recovery, 12mg
31%
Recovery time, 24mg
0%
no CI
Recovery time, 12mg
0%
no CI
Ivermectin Mirahmadizadeh et al. EARLY TREATMENT DB RCT
Is early treatment with ivermectin beneficial for COVID-19?
Double-blind RCT 261 patients in Iran (April - May 2021)
Lower ventilation (p=0.37) and hospitalization (p=0.22), not sig.
c19ivm.org
Mirahmadizadeh et al., Respirology, Jun 2022
Favors ivermectin
Favors control